Hot topics close
 

Muscular Dystrophy

Santhera Announces Completion of ReveraGen's Long-Term Extension Study with Vamorolone in Duchenne Muscular Dystrophy
1
  • Santhera Announces Completion of ReveraGen's Long-Term Extension Study with Vamorolone in Duchenne Muscular Dystrophy
  •  
This week's most popular news